LIPUM
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic inflammatory diseases. Lipum has a biological anti-inflammatory drug candidate developed against Rheumatoid Arthritis (RA) – an autoimmune disease characterized by chronic inflammation of the joints. It often causes disability and lowers the quality of life for millions. Lipum also addresses the treatment of Juvenile Idiopathic Arthritis (JIA) that is a rare disease affecting children. A nove... l biological drug for this disease may be considered for an orphan drug designation. Treatment of other chronic inflammatory conditions is also explored. Related diseases are such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis. Lipum's biological anti-inflammatory drug candidate provides a novel mechanism of action. Therefore, it is assumed to have less adverse effects than current treatments in use.
LIPUM
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Umeå, Vasterbottens Lan, Sweden
Country:
Sweden
Website Url:
http://www.lipum.se
Total Employee:
1+
Status:
Active
Contact:
+46 90 340 34 30
Total Funding:
351.19 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - LipUm
Almi Invest
Almi Invest investment in Seed Round - LipUm
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-08 | Lipum has recruited Helena Bergström as Chief Medical Officer |
Official Site Inspections
http://www.lipum.se Semrush global rank: 4.73 M Semrush visits lastest month: 2 K
- Host name: 252.254.228.35.bc.googleusercontent.com
- IP address: 35.228.254.252
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
More informations about "LipUm"
A presentation of the Board of Directors for Lipum AB
Board of Directors for Lipum AB. An experienced management team for development of Lipums biological drug directed towards the novel target molecule, ... & Commercial Officer (CCO) at …See details»
Corporate information and financial reports - Lipum AB
Here you can find corporate information and financial reports for Lipum AB. The information is presented in swedish language.See details»
LipUm - Crunchbase Company Profile & Funding
Organization. LipUm . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contact Email [email protected]; Phone Number +46 90 340 34 30; Lipum …See details»
Lipum has entered a partnership with QPS Netherlands
Mar 9, 2022 Web: www.lipum.se. About QPS HOLDINGS, LLC. Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) and life sciences products supplier …See details»
Lipum AB (publ) (STO: LIPUM) Company Profile & Overview
Nov 29, 2024 Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL …See details»
Lipum’s journey told by CSO and Co-founder - BioStock
Feb 16, 2023 Lipum was founded in 2010 after exciting discoveries. After further studies on the pro-inflammatory function of BSSL, the research group realised that the inflammation can be …See details»
Lipum AB receives 22 MSEK for developing anti-inflammatory drug
Aug 27, 2018 The team in Lipum is working on developing a new kind of treatment to help children suffering from a painful form of rheumatism. Fewer side-effects and effective pain …See details»
Lipum recruits new CMO: "I have been following their ... - BioStock
Aug 26, 2024 In preparation for the continued clinical development of SOL-116 in rheumatoid arthritis, Lipum has strengthened its management team by appointing Peter Hovstadius as the …See details»
About Lipum AB (publ)
Nov 24, 2024 Lipum is also evaluating other inflammatory diseases with significant unmet medical needs. Lipum’s office and a laboratory reside within Uminova Science Park in Umeå. …See details»
Industry case: With support from two SciLifeLab service …
Sep 8, 2023 Services. Overview Services provided by our national research infrastructure; Find services Find the right technology or expertise for your research project; Recent user publications Discover the latest research papers …See details»
interim report Q3 for the period July-September 2024 - Placera
Oct 25, 2024 The complete report (only in Swedish) is available at www.lipum.se. Contacts Ola Sandborgh, CEO [email protected] +46 72 218 80 21 Web: www.lipum.se. About Us …See details»
Lipum’s CEO summarizes the half-year - BioStock
Aug 15, 2024 Lipum and NorthX Biologics have already taken the initial steps in the manufacturing of SOL-116. The entire process from start to finish will take about 18 months …See details»
Presentation of the management at Lipum (publ) - Lipum AB …
Ola Sandborgh, CEO. Born: 1966 | Entered: 2023 Total shares with related parties and insurance: 37 500 Warrants A2 2021/2025: 0 Leading roles in different commercial, innovation and …See details»
Lipum – a novel treatment of chronic inflammations - UBI
Aug 29, 2018 Lipum develops a biological pharmaceutical for a novel mechanism of action in the treatment of chronic inflammations. The lead candidate drug (SOL-116) is a monoclonal …See details»
Lipum Presents Promising Data on Novel Antibody SOL-116 at …
Nov 18, 2024 [email protected] +46 72 218 80 21 Web: www.lipum.se. About Us Lipum AB (publ) is a clinical stage biopharmaceutical company specialized in discovery and …See details»
LipUm Company Information - Funding, Investors, and More
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
The story behind Lipum, a life science company in Sweden
Lipum AB (publ) was originally founded based on a discovery made by scientists at Umeå University. The history of the innovation goes back to the 1970s when Olle Hernell, Prof. of …See details»
LIPUM Stock Price Quote - Morningstar
Oct 2, 2024 Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases.See details»
See our lates press releases on our website - Lipum AB (publ)
Aug 19, 2024 Lipum AB (publ) announces that the multiple dose part of the phase I clinical study is completed. Eight healthy subjects have received four doses 28 days ... 2024-05-28 08:00 …See details»